Slóvenía - slóvenska - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

actavis group ptc ehf. - eplerenon - filmsko obložena tableta - eplerenon 25 mg / 1 tableta - eplerenon

Slóvenía - slóvenska - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

pfizer luxembourg sarl - eplerenon - filmsko obložena tableta - eplerenon 25 mg / 1 tableta - eplerenon

Slóvenía - slóvenska - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

pfizer luxembourg sarl - eplerenon - filmsko obložena tableta - eplerenon 50 mg / 1 tableta - eplerenon

Slóvenía - slóvenska - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

welding gmbh & co. kg - eplerenon - filmsko obložena tableta - eplerenon 25 mg / 1 tableta - eplerenon

Slóvenía - slóvenska - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

welding gmbh & co. kg - eplerenon - filmsko obložena tableta - eplerenon 50 mg / 1 tableta - eplerenon

Evrópusambandið - slóvenska - EMA (European Medicines Agency)

gilead sciences ireland uc - bulevirtide acetate - hepatitis d, chronic - antivirusi za sistemsko uporabo - hepcludex is indicated for the treatment of chronic hepatitis delta virus (hdv) infection in plasma (or serum) hdv-rna positive adult patients with compensated liver disease.

Evrópusambandið - slóvenska - EMA (European Medicines Agency)

pfizer europe ma eeig - nirmatrelvir, ritonavir - covid-19 virus infection - paxlovid is indicated for the treatment of coronavirus disease 2019 (covid-19) in adults who do not require supplemental oxygen and who are at increased risk for progressing to severe covid 19.

Evrópusambandið - slóvenska - EMA (European Medicines Agency)

nova laboratories ireland limited - spironolakton - edema; heart failure; liver cirrhosis; ascites; nephrotic syndrome; hyperaldosteronism; essential hypertension - antihypertensives and diuretics in combination - in the management of refractory oedema associated with congestive cardiac failure; hepatic cirrhosis with ascites and oedema, malignant ascites, nephrotic syndrome, diagnosis and treatment of primary aldosteronism, essential hypertension. neonates, children and adolescents should only be treated under guidance of a paediatric specialist (see sections 5. 1 in 5.

Evrópusambandið - slóvenska - EMA (European Medicines Agency)

proveca pharma limited - enalapril (maleate) - odpoved srca - sredstva, ki delujejo na sistem renin-angiotenzin - treatment of heart failure.

Evrópusambandið - slóvenska - EMA (European Medicines Agency)

novartis europharm limited - sacubitril, valsartan - odpoved srca - angiotensin ii antagonisti, druge kombinacije, agente, ki delujejo na renin-angiotensin sistem - paediatric heart failureentresto is indicated in children and adolescents aged one year or older for treatment of symptomatic chronic heart failure with left ventricular systolic dysfunction. adult heart failureentresto is indicated in adult patients for treatment of symptomatic chronic heart failure with reduced ejection fraction.